IP Verse

Controllable Drug Delivery System And Method Of Use - EP3151882B1

PatentPatent Analysis

EP3151882

AMGEN
Application Number
EP15728736A
Filing Date
Jun 3, 2015
Status
Granted And Under Opposition
Mar 8, 2024
Grant Date
Apr 10, 2024
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3661562B1
EP3570885B1
EP4209499B1

Bibliography

The patent EP3151882B1 was granted to Amgen on Apr 10, 2024 following the initial filing on Jun 3, 2015 under the application number EP15728736A . The current legal status of the patent is Granted And Under Opposition.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

STEINBACHJan 9, 2025ADMISSIBLE
YPSOMEDDec 18, 2024ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents